Skip to Main Content

Paper Details

Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives.
Exp Biol Med (Maywood)
42
2017
Author NameAffiliation
Charles Patrick Reynolds1 Cancer Center, Texas Tech University Health Sciences Center
Charles Patrick ReynoldsTexas Tech University Health Sciences Center
Charles Patrick ReynoldsTexas Tech University Health Sciences Center
Charles Patrick ReynoldsTexas Tech University Health Sciences Center
Charles Patrick ReynoldsTexas Tech University Health Sciences Center
  • 1 - 5

Datasets